Canaccord Genuity Group Reaffirms Buy Rating for Atara Biotherapeutics (NASDAQ:ATRA)
Canaccord Genuity Group reaffirmed their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) in a research report report published on Tuesday morning, Benzinga reports. They currently have a $13.00 target price on the biotechnology company’s stock. ATRA has been the subject of a number of other research reports. HC Wainwright restated a […]
More Stories
Long Story Short Season 2 Is Renewed! Release Date, Plot, and More
Netflix has recently given anime fans a major reason to celebrate by renewing Long Story Short for a new season....
MGA, Curaçao, and German Licences: What the Differences Mean for Users
Choosing an online casino often comes down to one detail most players skim past: the licence badge in the footer....
Is I Will Find You Season 2 Returning? Renewal Status, Cast, and Plot
In 2026, the first season of the popular and most awaited series was released. I Will Find You first dropped...
Top Ahrefs SEO Tools to Boost a Website’s Traffic and Sales
Website analysis has become one of the most useful SEO tools used by several companies nowadays. Ahrefs SEO tool provides...
Planning Group Travel That Doesn’t Fall Apart at the Logistics Stage
Anyone who has organized transportation for a wedding party, a school trip, or a corporate retreat knows the pattern. The...
Black Doves Season 2 is Coming Soon! Release Date, Cast Members, and Production Updates
Good news! The release date for the popular spy-action drama Black Doves Season 2 is out. Keira Knightley is returning...